Wells Fargo & Company Nano Vibronix, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.25 - $9.02 $1 - $45	5 Added 2.69%	191 $0
Q3 2022 Nov 14, 2022	SELL	$0.43 - $10.32 $0 - $10	-1 Reduced 0.53%	186 $0
Q2 2022 Aug 12, 2022	SELL	$0.55 - $1.19 $1,366 - $2,957	-2,485 Reduced 93.0%	187 $0
Q1 2022 May 16, 2022	BUY	$0.7 - $1.16 $1,750 - $2,901	2,501 Added 1462.57%	2,672 $3,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.0 $23 - $46	23 Added 15.54%	171 $0
Q3 2021 Nov 15, 2021	BUY	$0.7 - $3.37 $5 - $26	8 Added 5.71%	148 $0
Q2 2021 Aug 16, 2021	SELL	$0.79 - $1.15 $0 - $1	-1 Reduced 0.71%	140 $0
Q1 2021 May 13, 2021	BUY	$0.83 - $1.51 $52 - $95	63 Added 80.77%	141 $0
Q4 2020 Feb 09, 2021	BUY	$0.56 - $1.13 $30 - $62	55 Added 239.13%	78 $0
Q3 2020 Nov 05, 2020	BUY	$0.59 - $2.24 $5 - $22	10 Added 76.92%	23 $0
Q1 2020 May 14, 2020	BUY	$1.95 - $2.9 $25 - $37	13 New	13 $0

Ticker NAOV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,997,800
Market Cap $16.2M
Description
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.